NHS will offer pembrolizumab cervical cancer drug in England

NHS England’s director of specialised commissioning and interim commercial medicines director, John Stewart, said: “After nearly 15 years without a new treatment for this type of advanced cervical cancer, this first immunotherapy marks a significant step forward that will provide hundreds of people with precious time with their loved ones.

Share With Friends

Leave a Reply

Your email address will not be published. Required fields are marked *